(Q43907228)

27 November 2017

title

The antithrombotic effect of angiotensin-(1-7) closely resembles that of losartan (English)

1 reference

27 November 2017

T Matys

4

0 references

Ewa Chabielska

object named as

E Chabielska

2

0 references

Dariusz Pawlak

object named as

D Pawlak

3

0 references

author name string

I Kucharewicz

1

1 reference

27 November 2017

R Rólkowski

5

1 reference

27 November 2017

W Buczko

6

1 reference

27 November 2017

language of work or name

1 reference

1 September 2000

1 reference

Journal of the Renin-Angiotensin-Aldosterone System

27 November 2017

published in

1 reference

27 November 2017

volume

1

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

268-272

1 reference

Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

Losartan, an orally active angiotensin (AT1) receptor antagonist: a review of its efficacy and safety in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

Counterregulatory actions of angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

Losartan inhibits thromboxane A2-induced platelet aggregation and vascular constriction in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

DuP 753, the selective angiotensin II receptor blocker, is a competitive antagonist to human platelet thromboxane A2/prostaglandin H2 (TP) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3317%2FJRAAS.2000.041

21 January 2018

Identifiers

DOI

10.3317/JRAAS.2000.041

1 reference

27 November 2017

1 reference